Project Grant R35GM165845
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $375,633 to the University of Nevada, Las Vegas (UNLV) under the Biomedical Research and Research Training program (CFDA 93.859) on August 7, 2025, for a five-year project extending through July 31, 2030. The award supports fundamental research to develop and engineer lipid nanoparticle (LNP) platforms designed to improve selective and enhanced delivery of messenger RNA (mRNA) therapeutics in...
- Federal Project Grant Award Summary The University of Nevada, Las Vegas (UNLV), received a $147,091 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2029. The project focuses on developing an innovative plasmonic nanoantenna-enhanced ultrasensitive fluorescence immunoassay technology integrated with super-hydrophobic surfaces to enable...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $411,739 to the University of Nevada, Las Vegas (UNLV) on May 21, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) for a project period extending through February 28, 2031. The project, "Revealing the Cullin-Ring Ligase Code," advances fundamental understanding of cullin-ring ligases (CRLs), which represent approximately half of all ubiquitin ligases...
- Federal Grant Award Summary The University of Nevada, Las Vegas received a $264,561 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through April 30, 2031. The G-RISE (Graduate Research Initiative for Student Excellence) program delivers a comprehensive doctoral-level training initiative designed to increase diversity within UNLV's biomedical PhD programs by...
- Federal Project Grant Award Summary The University of Nevada, Reno received a $400,178 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 8, 2025, with a completion date of July 31, 2030. The award supports fundamental research in protein engineering and design, specifically focused on developing engineered modular protein inhibitors for selective targeting of pathological...
- Federal Project Grant Award Summary The University of Utah received a $392,942 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 22, 2026 through February 28, 2030. This award funds fundamental biomedical research investigating the regulation of single-cell migration in vivo, with a specific focus on understanding focal adhesion organization and dynamics during cell...
- This $852,499 Project Grant award, provided by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), will support research led by the University of Nevada, Las Vegas (UNLV) to investigate the molecular mechanisms underlying epithelial-mesenchymal plasticity. The project aims to elucidate how cells transition between epithelial and mesenchymal states, which is essential for generating diverse cell types during development and wound healing. Key objectives include: 1)...
- Federal Project Grant Award Summary The University of Nevada, Las Vegas received a $149,582 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on July 21, 2025, with completion targeted for June 30, 2029. The award supports fundamental biomedical research investigating the regulation of hematopoiesis (blood cell formation) by the EZH2-PRC2 (enhancer of zeste homolog 2-polycomb...
- Federal Project Grant Award Summary The University of Nevada, Las Vegas received a $679,856 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) for the period September 1, 2025 through August 31, 2027. The grant supports fundamental research investigating the mechanism of lysine methylation-dependent proteolysis in non-histone proteins. The research will systematically examine how specific...
- Federal Grant Award Summary The University of Nebraska Board of Regents received a $2.04 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 8, 2025, with completion targeted for July 31, 2029. This award supports fundamental research investigating the ARP2/3 complex—a critical protein assembly system essential to cellular processes including cell migration, tissue...
The University of Nevada, Las Vegas (UNLV), received a $410,545 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) beginning July 1, 2026, with a completion date of June 30, 2031. This five-year research initiative investigates cell polarity signaling mechanisms that drive collective epithelial cell behaviors essential for tissue development and maintenance. The project integrates complementary research approaches utilizing Drosophila border cell migration models—leveraging their genetic power and single-cell resolution capabilities—with pancreatic organoid experiments to establish physiologically relevant findings. The research focuses on the protein Scribble, which regulates cell adhesion and Rho-family GTPase activity and is frequently amplified or misregulated in human cancers. The project delivers fundamental scientific knowledge through experimental research designed to define how polarity signaling stabilizes cell adhesion, sculpts small GTPase activity in vivo, and regulates lumen formation, force generation, and morphogenesis under mechanical confinement. Research outcomes will establish a unified framework of how polarity signaling generates emergent epithelial behaviors across molecular to tissue scales, with applications extending to understanding how cancer cells exploit polarity pathways to adapt to stiff, fibrotic microenvironments. This basic research advances the broader scientific understanding of collective cell migration and growth principles while providing conceptual models relevant to cancer biology and cell behavior under mechanical stress.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $410.5k | 6/15/26 |